Related Experiment Video
Updated: Apr 16, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Central serous chorioretinopathy treatment with spironolactone: a challenge-rechallenge case
Edwin H Ryan1, Christine M Pulido
1VitreoRetinal Surgery, PA, Edina, Minnesota.
Purpose:
To present a case of central serous chorioretinopathy (CSC) treatment with spironolactone in a challenge-rechallenge pattern.
Methods:
At presentation, fundus photography, fluorescein angiography, spectral domain optical coherence tomography, and enhanced depth imaging ocular coherence tomography were performed in both eyes. The patient was prescribed 25 mg spironolactone daily along with serum potassium monitoring. At follow-ups, spectral domain optical coherence tomography and enhanced depth imaging ocular coherence tomography were performed.
Results:
A 37-year-old white male accountant presenting with CSC. Spironolactone treatment resolved the CSC. After the patient discontinued treatment, it returned. After returning to daily treatment, the CSC again resolved.
Conclusion:
Spironolactone was an effective treatment of CSC in this case. Other groups have reported similar findings with eplerenone, a similar drug.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management

